CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

TOWARD HEALTH Announces 120-Patient Study Showing Major Improvements in AHA PREVENT-Estimated Cardiovascular Risk

Data ReadoutpositiveTOWARD Health metabolic continuous-care interventionPositive
AI Analysis

Summary

TOWARD HEALTH announced results from a 120-patient study demonstrating that its physician-led metabolic continuous-care intervention reduced estimated 10-year ASCVD risk by 29% and total cardiovascular risk by 28% after one year of treatment.

Clinical Trial Data

Primary Endpoint

Met

Patients

120

Outcome Details

120-patient study showed 29% reduction in estimated 10-year ASCVD risk and 28% reduction in total cardiovascular risk after one year of physician-led metabolic continuous-care intervention

Importance:6/10
Sentiment:
0.75
cardiovascularmetabolic interventionrisk reductionclinical study
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on October 5, 2026 3:40 PM

Read Original